T1	Participants 41 93	after bone marrow transplantation by pentoxifylline:
T2	Participants 282 316	bone marrow transplantation (BMT).
T3	Participants 521 545	patients undergoing BMT.
T4	Participants 611 689	140 patients undergoing either allogeneic (n = 51) or autologous BMT (n = 89).
T5	Participants 1921 1931	after BMT.
